In addition, research has shown that the co-application of prostate stem cell antigen (PSCA)-targeted and mucin 1 (MUC1)-targeted CAR-T cells effectively eradicated cancer cells in individuals diagnosed with PSCA + and MUC1 + non-small cell lung cancer (NSCLC) [25]. This evidence concerns the gene MUC1 and non-small cell lung carcinoma.